Department of Medicine, Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.
Hum Genet. 2013 Jun;132(6):603-17. doi: 10.1007/s00439-013-1286-3. Epub 2013 Mar 17.
The concept that a specific alteration in an individual's DNA can result in disease is central to our notion of molecular medicine. The molecular basis of more than 3,500 Mendelian disorders has now been identified. In contrast, the identification of genes for common disease has been much more challenging. We discuss historical and contemporary approaches to disease gene identification, focusing on novel opportunities such as the use of population extremes and the identification of rare variants. While our ability to sequence DNA has advanced dramatically, assigning function to a given sequence change remains a major challenge, highlighting the need for both bioinformatics and functional approaches to appropriately interpret these data. We review progress in mapping and identifying human disease genes and discuss future challenges and opportunities for the field.
个体 DNA 的特定改变会导致疾病,这一概念是分子医学的核心。现在已经确定了超过 3500 种孟德尔疾病的分子基础。相比之下,常见疾病基因的鉴定要困难得多。我们讨论了疾病基因鉴定的历史和当代方法,重点介绍了利用群体极端和鉴定罕见变异等新的机会。虽然我们的 DNA 测序能力有了显著提高,但赋予给定序列变化功能仍然是一个主要挑战,这突出表明需要生物信息学和功能方法来恰当地解释这些数据。我们回顾了人类疾病基因定位和鉴定的进展,并讨论了该领域未来的挑战和机遇。